These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 12446422)
1. Myelodysplastic syndromes. Greenberg PL; Young NS; Gattermann N Hematology Am Soc Hematol Educ Program; 2002; ():136-61. PubMed ID: 12446422 [TBL] [Abstract][Full Text] [Related]
2. [Relationship of mitochondrial DNA mutation with myelodysplastic syndromes - review]. Hou L; Liu T Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):709-12. PubMed ID: 16129066 [TBL] [Abstract][Full Text] [Related]
3. Physician Education: Myelodysplastic Syndrome. Yoshida Y Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts. Malcovati L; Cazzola M Br J Haematol; 2016 Sep; 174(6):847-58. PubMed ID: 27391606 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in the understanding of iron overload in sideroblastic myelodysplastic syndrome. Cuijpers ML; Raymakers RA; Mackenzie MA; de Witte TJ; Swinkels DW Br J Haematol; 2010 May; 149(3):322-33. PubMed ID: 20067561 [TBL] [Abstract][Full Text] [Related]
6. Refractory anemia with ring sideroblasts and RARS with thrombocytosis. Patnaik MM; Tefferi A Am J Hematol; 2015 Jun; 90(6):549-59. PubMed ID: 25899435 [TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndromes in the elderly: the role of growth factors in management. Saba HI Leuk Res; 1996 Mar; 20(3):203-19. PubMed ID: 8637215 [TBL] [Abstract][Full Text] [Related]
9. Hemochromatosis-associated gene mutations in patients with myelodysplastic syndromes with refractory anemia with ringed sideroblasts. Nearman ZP; Szpurka H; Serio B; Warshawksy I; Theil K; Lichtin A; Sekeres MA; Maciejewski JP Am J Hematol; 2007 Dec; 82(12):1076-9. PubMed ID: 17654685 [TBL] [Abstract][Full Text] [Related]
10. The role of JAK2 mutations in RARS and other MDS. Hellström-Lindberg E; Cazzola M Hematology Am Soc Hematol Educ Program; 2008; ():52-9. PubMed ID: 19074058 [TBL] [Abstract][Full Text] [Related]
11. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome. Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932 [TBL] [Abstract][Full Text] [Related]
12. Treatment of Acquired Sideroblastic Anemias. Mangaonkar AA; Patnaik MM Hematol Oncol Clin North Am; 2020 Apr; 34(2):401-420. PubMed ID: 32089219 [TBL] [Abstract][Full Text] [Related]
13. Special Education: Aplastic Anemia. Teramura M; Mizoguchi H Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986 [TBL] [Abstract][Full Text] [Related]
14. [Gene mutation and myelodysplastic syndromes with ring sideroblast excess]. Meng FK; Huang LF; Zhou JF; Sun HY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1088-90. PubMed ID: 23998618 [TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology? Barrett J; Saunthararajah Y; Molldrem J Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908 [TBL] [Abstract][Full Text] [Related]